SPK-8016 clinical trials

Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A

This study looks at the long-term safety and effectiveness of new gene therapies, SPK-8011 and SPK-8016, for men with haemophilia A. It follows participants who have already received one of these treatments to see how they're doing over many years.